GlobeNewswire by notified

Wolters Kluwer to divest its U.S. legal education business

Share

Wolters Kluwer to divestits U.S. legal education business

September 27, 2021Wolters Kluwer Legal & Regulatory U.S.announces that it has signeda binding agreement tosellits U.S. legal education business to Transom Capital Group for $88 million in cash.Wolters Kluwer intends to deploy the post-tax proceeds towards additional share repurchases to mitigate theadjusted EPSdilution related to the disposal.

The divestment will allow Wolters Kluwer Legal & Regulatory U.S. to further advance its focus on supporting legal professionals with the domain expertise and state-of-the-art solutions that they need.

The U.S. legal education business, which mainly produces textbooks and innovative digital educational solutions for law students, recorded revenues of $33 million in 2020 and is profitable. The iconic red and black books have become synonymous with top-quality content. The business has about 50 full-time employees.

“After careful consideration, we are delighted to have found a new owner for the legal education business who recognizes the value of our highly regarded content and solutions and who is committed to further growing the business,” said Dean Sonderegger, Senior Vice President and General Manager, Wolters Kluwer Legal & Regulatory U.S. “We are confident that Transom Capital Group will continue to serve authors, faculty, students and others in the legal education community with excellence.”

James Oh, Managing Partner of Transom Capital Group said, “We look forward to serving the legal education community as we further invest and grow the business. One of Transom’s core strategies has been investing in market-leading brands. We look forward to continuing the success the business has accomplished and investing in various growth avenues available to the business. We respect and admire the team that will now become part the Transom family.”

Completion of the disposal is subject to customary closing conditions and is expected to take several months. The divestment is expected to result in a one-time (non-benchmark) capital gain. Upon completion, Wolters Kluwer intends to deploy the post-tax proceeds of approximately €60 million towards additional share repurchases in order to mitigate the expected dilution to adjusted earnings per share from the sale.

About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

MediaInvestors/Analysts
Gerbert van Genderen Stort                                 Meg Geldens
Corporate Communications                                  Investor Relations
t + 31 172 641 230                                                t + 31 172 641 407        
g.van.genderen.stort@wolterskluwer.comir@wolterskluwer.com

Forward-looking Statements and Other Important Legal Information
This report contains forward-looking statements. These statements may be identified by words such as “expect”, “should”, “could”, “shall” and similar expressions. Wolters Kluwer cautions
that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This press release contains information which is to be made publicly available under Regulation (EU) 596/2014.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

DECISIONS OF DIGITALIST GROUP PLC’S ANNUAL GENERAL MEETING 25 APRIL 2024 AND THE ORGANIZING MEETING OF THE BOARD OF DIRECTORS25.4.2024 19:00:00 CEST | Press release

DECISIONS OF DIGITALIST GROUP PLC’S ANNUAL GENERAL MEETING 25 APRIL 2024 AND THE ORGANIZING MEETING OF THE BOARD OF DIRECTORS Digitalist Group Oyj Stock Exchange Release 25 April 2024 at 20:00 DECISIONS OF DIGITALIST GROUP PLC’S ANNUAL GENERAL MEETING 25 APRIL 2024 Adoption of the financial statements The Annual General Meeting of Digitalist Group Plc (the “Company”) adopted the Company’s financial statements and consolidated financial statements for the financial period 1 January -31 December 2023. Resolution on the use of the loss shown on the balance sheet and on the distribution of assets The Annual General Meeting resolved that the loss EUR 4,575,895.22 indicated by the financial statements for 2023 be recorded in the Company’s profit and loss account, and that no dividend be paid to shareholders for the financial period 2023. Resolution on the discharge of the members of the Board of Directors and the CEO from liability for the financial period 1 January 2023 to 31 December 2023

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC25.4.2024 19:00:00 CEST | Press release

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – April 25, 2024 – 07:00 PM CET (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on April 25, 2024, from Atlas Special Opportunities, LLC indicating that as of April 19, 2024, it held 380,755,774 shares of the then outstanding 9,014,821,287 shares, and therefore crossed below the threshold (5%) by virtue of the sale of voting securities. See Annex 1. About Oxurion Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com. Important information about forward-looking statements Certain statements in this press release may

Heineken Holding N.V. Annual General Meeting of Shareholders adopts all proposals25.4.2024 18:31:00 CEST | Press release

Amsterdam, 25 April 2024 - Heineken Holding N.V. announced today that its Annual General Meeting of Shareholders (AGM) has adopted all proposals on the agenda of the AGM. The most important resolutions and announcements are listed below. Dividend The Board of Directors announced the distribution of a dividend for the year 2023 of EUR 1.73 per share. As an interim dividend of EUR 0.69 was paid on 10 August 2023, the final dividend of EUR 1.04 per share will be made payable on 7 May 2024. Heineken Holding N.V. shares will be quoted ex-dividend on 29 April 2024. Reappointment of Mr J.F.M.L. van Boxmeer as non-executive member of the Board of Directors The AGM reappointed Mr J.F.M.L. van Boxmeer as non-executive member of the Board of Directors for a four-year term. Appointment of External Auditor The AGM appointed KPMG Accountants N.V. as external auditor for the financial year 2025. The voting results per agenda item of the AGM of Heineken Holding N.V. of 25 April 2024 can be found on th

Heineken N.V. Annual General Meeting adopts all proposals25.4.2024 18:30:00 CEST | Press release

Amsterdam, 25 April 2024 - Heineken N.V. (HEINEKEN) announced today that its Annual General Meeting of Shareholders (AGM) has adopted all proposals on the agenda of the AGM. The most important resolutions are listed below. Re-appointment of Executive Board Member The AGM re-appointed Dolf van den Brink as member of the Executive Board for a period of four years, until the end of the AGM to be held in 2028. Dividend The AGM adopted the dividend proposal for the year 2023 of EUR 1.73 per share. As an interim dividend of EUR 0.69 was paid on 10 August 2023, the final dividend of EUR 1.04 per share will be made payable on 7 May 2024. Heineken N.V. shares will be quoted ex-dividend on 29 April 2024. Re-appointment of Supervisory Board Member The AGM re-appointed Jean-Marc Huët as member of the Supervisory Board for a two-year term. Re-appointment of Supervisory Board Member The AGM re-appointed Pamela Mars Wright as member of the Supervisory Board for a two-year term. Appointment of Supervi

Havila Kystruten AS: Integrated Annual Report for 202325.4.2024 18:04:39 CEST | Press release

The board of directors of Havila Kystruten AS has today approved the financial statements and annual report for 2023, which integrates financial and sustainability reporting. The report is attached in PDF format along with a visual presentation summarizing the year and highlighting the company's fundamental focus on the environment and sustainability. The annual financial statements have been adjusted compared to the preliminary and unaudited result for 2023, which was presented on February 28, 2024. There has been a write-down of the inventory value by NOK 11.2 million, with corresponding effects on the income statement and balance sheet. Further information is available in note 15 of the consolidated financial statements. Contacts: Chief Executive Officer Bent Martini, +47 905 99 650 Chief Financial Officer Aleksander Røynesdal, +47 413 18 114 Attachments HKY_Integrated Annual Report 2023HKY_Integrated Annual Report Presentation 2023HKY_Integrert arsrapport 2023

HiddenA line styled icon from Orion Icon Library.Eye